369 related articles for article (PubMed ID: 35434595)
1. Peptide-based delivery of therapeutics in cancer treatment.
Samec T; Boulos J; Gilmore S; Hazelton A; Alexander-Bryant A
Mater Today Bio; 2022 Mar; 14():100248. PubMed ID: 35434595
[TBL] [Abstract][Full Text] [Related]
2. Applications of cell-penetrating peptides for tumor targeting and future cancer therapies.
Regberg J; Srimanee A; Langel U
Pharmaceuticals (Basel); 2012 Sep; 5(9):991-1007. PubMed ID: 24280701
[TBL] [Abstract][Full Text] [Related]
3. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM
Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251
[TBL] [Abstract][Full Text] [Related]
4. Peptide cargo administration: current state and applications.
Rohira H; Arora A; Kaur P; Chugh A
Appl Microbiol Biotechnol; 2023 May; 107(10):3153-3181. PubMed ID: 37052636
[TBL] [Abstract][Full Text] [Related]
5. Peptide-functionalized delivery vehicles for enhanced cancer therapy.
Tang SY; Wei H; Yu CY
Int J Pharm; 2021 Jan; 593():120141. PubMed ID: 33279713
[TBL] [Abstract][Full Text] [Related]
6. The significance of transferrin receptors in oncology: the development of functional nano-based drug delivery systems.
Tortorella S; Karagiannis TC
Curr Drug Deliv; 2014; 11(4):427-43. PubMed ID: 24387131
[TBL] [Abstract][Full Text] [Related]
7. Status update in the use of cell-penetrating peptides for the delivery of macromolecular therapeutics.
Kurrikoff K; Vunk B; Langel Ü
Expert Opin Biol Ther; 2021 Mar; 21(3):361-370. PubMed ID: 32938243
[TBL] [Abstract][Full Text] [Related]
8. Selective Uptake Into Drug Resistant Mammalian Cancer by Cell Penetrating Peptide-Mediated Delivery.
Carnevale KJF; Muroski ME; Vakil PN; Foley ME; Laufersky G; Kenworthy R; Zorio DAR; Morgan TJ; Levenson CW; Strouse GF
Bioconjug Chem; 2018 Oct; 29(10):3273-3284. PubMed ID: 30240193
[TBL] [Abstract][Full Text] [Related]
9. From phage display to nanoparticle delivery: functionalizing liposomes with multivalent peptides improves targeting to a cancer biomarker.
Gray BP; Li S; Brown KC
Bioconjug Chem; 2013 Jan; 24(1):85-96. PubMed ID: 23186007
[TBL] [Abstract][Full Text] [Related]
10. Cell penetrating elastin-like polypeptides for therapeutic peptide delivery.
Bidwell GL; Raucher D
Adv Drug Deliv Rev; 2010 Dec; 62(15):1486-96. PubMed ID: 20478348
[TBL] [Abstract][Full Text] [Related]
11. Structural polymorphism of non-covalent peptide-based delivery systems: highway to cellular uptake.
Deshayes S; Konate K; Aldrian G; Crombez L; Heitz F; Divita G
Biochim Biophys Acta; 2010 Dec; 1798(12):2304-14. PubMed ID: 20541523
[TBL] [Abstract][Full Text] [Related]
12. Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers.
Kebebe D; Liu Y; Wu Y; Vilakhamxay M; Liu Z; Li J
Int J Nanomedicine; 2018; 13():1425-1442. PubMed ID: 29563797
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
14. Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides.
Dissanayake S; Denny WA; Gamage S; Sarojini V
J Control Release; 2017 Mar; 250():62-76. PubMed ID: 28167286
[TBL] [Abstract][Full Text] [Related]
15. Peptide-based targeted therapeutics: Focus on cancer treatment.
Araste F; Abnous K; Hashemi M; Taghdisi SM; Ramezani M; Alibolandi M
J Control Release; 2018 Dec; 292():141-162. PubMed ID: 30408554
[TBL] [Abstract][Full Text] [Related]
16. Current Aspects of siRNA Bioconjugate for In Vitro and In Vivo Delivery.
Tai W
Molecules; 2019 Jun; 24(12):. PubMed ID: 31200490
[TBL] [Abstract][Full Text] [Related]
17. Anti-cancer peptide-based therapeutic strategies in solid tumors.
Karami Fath M; Babakhaniyan K; Zokaei M; Yaghoubian A; Akbari S; Khorsandi M; Soofi A; Nabi-Afjadi M; Zalpoor H; Jalalifar F; Azargoonjahromi A; Payandeh Z; Alagheband Bahrami A
Cell Mol Biol Lett; 2022 Apr; 27(1):33. PubMed ID: 35397496
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in selective and targeted drug/gene delivery systems using cell-penetrating peptides.
Nam SH; Park J; Koo H
Arch Pharm Res; 2023 Jan; 46(1):18-34. PubMed ID: 36593377
[TBL] [Abstract][Full Text] [Related]
19. Fusogenic-oligoarginine peptide-mediated delivery of siRNAs targeting the CIP2A oncogene into oral cancer cells.
Cantini L; Attaway CC; Butler B; Andino LM; Sokolosky ML; Jakymiw A
PLoS One; 2013; 8(9):e73348. PubMed ID: 24019920
[TBL] [Abstract][Full Text] [Related]
20. Smart Cell-Penetrating Peptide-Based Techniques for Intracellular Delivery of Therapeutic Macromolecules.
He Y; Li F; Huang Y
Adv Protein Chem Struct Biol; 2018; 112():183-220. PubMed ID: 29680237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
